(Q43829207)

English

Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner

scientific article published on 21 June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner (English)

1 reference

Europe PubMed Central

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

2

object named as

Kei Kawana

1 reference

Europe PubMed Central

27 November 2017

8

object named as

Katsutoshi Oda

1 reference

Europe PubMed Central

27 November 2017

1

object named as

Ayumi Taguchi

1 reference

Europe PubMed Central

27 November 2017

Katsuyuki Adachi

4

object named as

Katsuyuki Adachi

1 reference

Europe PubMed Central

27 November 2017

6

object named as

Kensuke Tomio

1 reference

Europe PubMed Central

27 November 2017

author name string

Terufumi Yokoyama

3

1 reference

Europe PubMed Central

27 November 2017

Aki Yamashita

5

1 reference

Europe PubMed Central

27 November 2017

Satoko Kojima

7

1 reference

Europe PubMed Central

27 November 2017

Tomoyuki Fujii

9

1 reference

Europe PubMed Central

27 November 2017

Shiro Kozuma

10

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

21 June 2012

1 reference

Europe PubMed Central

27 November 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

27 November 2017

30

1 reference

Europe PubMed Central

27 November 2017

36

1 reference

Europe PubMed Central

27 November 2017

5368-5372

1 reference

Europe PubMed Central

27 November 2017

High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Development of therapeutic HPV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Analysis of adhesion molecules involved in leukocyte homing into the basolateral pockets of mouse Peyer's patch M cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Stimulating effect of Japanese herbal (kampo) medicine, hochuekkito on upper respiratory mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

The immune enhancement of propolis adjuvant on inactivated porcine parvovirus vaccine in guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Stimulation of tetanus toxoid-specific immune responses by a traditional Chinese herbal medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

A Kampo medicine "Juzen-taiho-to"--prevention of malignant progression and metastasis of tumor cells and the mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Hochuekkito, a Kampo (traditional Japanese herbal) Medicine, Enhances Mucosal IgA Antibody Response in Mice Immunized with Antigen-entrapped Biodegradable Microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.027

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.06.027

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43829207&oldid=2153502492"